A comparative study of PDGFR inhibition with imatinib on radiolabeled antibody targeting and clearance in two pathologically distinct models of colon adenocarcinoma.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Volumn 33, Issue 6, 2012, Pages 2019-2029

  Rajkumar, Vineeth S ^a   Boxer, Geoff ^b   Robson, Mathew ^b   Muddle, John ^b   Papastavrou, Yanni ^b   Pedley, R Barbara ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN; IMATINIB; MONOCLONAL ANTIBODY; PIPERAZINE DERIVATIVE; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PYRIMIDINE DERIVATIVE;

ADENOCARCINOMA; ANIMAL; ARTICLE; COLORECTAL TUMOR; DISEASE MODEL; DRUG ANTAGONISM; ENZYME IMMUNOASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; MULTIMODALITY CANCER THERAPY; NUDE MOUSE; PATHOLOGY; RADIOIMMUNOTHERAPY; TISSUE DISTRIBUTION; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; MICE; MICE, NUDE; PIPERAZINES; PYRIMIDINES; RADIOIMMUNOTHERAPY; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84930867337     PISSN: None     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0461-9     Document Type: Article

References (0)